Cosmo Pharmaceuticals saw the highest growth of 199% in patent filings in January and 99% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 199% and grants by 49%. GlobalData’s DataBook provides a comprehensive analysis of Cosmo Pharmaceuticals’s patent filings and grants. Buy the databook here.
Cosmo Pharmaceuticals has been focused on protecting inventions in Australia(AU) with three publications in Q1 2024
The Australia(AU) Patent Office dominates the patent filings and grants with nearly 20% filings and 33% grants. The World Intellectual Property Organization(WIPO), Australia(AU), Argentina(AR), and China(CN) patent Office are among the top ten patent offices where Cosmo Pharmaceuticals is filings its patents. Among the top granted patent authorities, Cosmo Pharmaceuticals has 67% of its grants in United States(US) and 33% in Australia(AU).
F. Hoffmann-La Roche could be the strongest competitor for Cosmo Pharmaceuticals
Patents related to healthtech and computer vision lead Cosmo Pharmaceuticals's portfolio
Cosmo Pharmaceuticals has the highest number of patents in healthtech followed by, computer vision and remote patient monitoring. For healthtech, nearly 25% of patents were filed and 25% of patents were granted in Q1 2024.
Image management related patents lead Cosmo Pharmaceuticals portfolio followed by digital signal processors(dsp), and healthcare it
Cosmo Pharmaceuticals has highest number of patents in image management followed by digital signal processors(dsp), healthcare it, electronic medical records, and diagnostic imaging. For image management, nearly 24% of patents were filed and 10% of patents were granted in Q1 2024.
For comprehensive analysis of Cosmo Pharmaceuticals's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.